Works by Ryan, Christopher W.


Results: 58
    1

    Dual anti-CTLA-4 and anti-PD-1 blockade in metastatic basal cell carcinoma.

    Published in:
    NPJ Precision Oncology, 2025, v. 9, n. 1, p. 1, doi. 10.1038/s41698-024-00798-1
    By:
    • Patel, Sandip P.;
    • Cano-Linson, Eleanor;
    • Chae, Young Kwang;
    • Schokrpur, Shiruyeh;
    • Lao, Christopher D.;
    • Powers, Benjamin C.;
    • Victor, Adrienne I.;
    • Onitilo, Adedayo A.;
    • Shin, Sarah;
    • Takebe, Naoko;
    • Threlkel, Sara;
    • McLeod, Christine M.;
    • Chen, Helen X.;
    • Sharon, Elad;
    • Othus, Megan;
    • Ryan, Christopher W.;
    • Blanke, Charles D.;
    • Kurzrock, Razelle
    Publication type:
    Article
    2
    3
    4
    5

    A Prospective Multicenter Evaluation of Initial Treatment Choice in Metastatic Renal Cell Carcinoma Prior to the Immunotherapy Era: The MaRCC Registry Experience.

    Published in:
    Clinical Genitourinary Cancer, 2022, v. 20, n. 1, p. 1, doi. 10.1016/j.clgc.2021.07.002
    By:
    • Costello, Brian A.;
    • Bhavsar, Nrupen A.;
    • Zakharia, Yousef;
    • Pal, Sumanta K.;
    • Vaishampayan, Ulka;
    • Jim, Heather;
    • Fishman, Mayer N.;
    • Molina, Ana M.;
    • Kyriakopoulos, Christos E.;
    • Che-Kai Tsao;
    • Appleman, Leonard J.;
    • Gartrell, Benjamin A.;
    • Hussain, Arif;
    • Stadler, Walter M.;
    • Agarwal, Neeraj;
    • Pachynski, Russell K.;
    • Hutson, Thomas E.;
    • Hammers, Hans J.;
    • Ryan, Christopher W.;
    • Mardekian, Jack
    Publication type:
    Article
    6
    7
    8

    Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma.

    Published in:
    2019
    By:
    • Patel, Shreyaskumar;
    • von Mehren, Margaret;
    • Reed, Damon R.;
    • Kaiser, Pamela;
    • Charlson, John;
    • Ryan, Christopher W.;
    • Rushing, Daniel;
    • Livingston, Michael;
    • Singh, Arun;
    • Seth, Rahul;
    • Forscher, Charles;
    • D'Amato, Gina;
    • Chawla, Sant P.;
    • McCarthy, Sharon;
    • Wang, George;
    • Parekh, Trilok;
    • Knoblauch, Roland;
    • Hensley, Martee L.;
    • Maki, Robert G.;
    • Demetri, George D.
    Publication type:
    journal article
    9
    10

    Safety and Efficacy Results of the Advanced Renal Cell Carcinoma Sorafenib Expanded Access Program in North America.

    Published in:
    Cancer (0008543X), 2010, v. 116, n. 5, p. 1272, doi. 10.1002/cncr.24864
    By:
    • Stadler, Walter M.;
    • Figlin, Robert A.;
    • McDermott, David F.;
    • Dutcher, Janice P.;
    • Knox, Jennifer J.;
    • Miller Jr., Wilson H.;
    • Hainsworth, John D.;
    • Henderson, Charles A.;
    • George, Jeffrey R.;
    • Hajdenberg, Julio;
    • Kindwall-Keller, Tamila L.;
    • Ernstoff, Marc S.;
    • Drabkin, Harry A.;
    • Curti, Brendan D.;
    • Chu, Luis;
    • Ryan, Christopher W.;
    • Hotte, Sebastien J.;
    • Xia, Chenghua;
    • Cupit, Lisa;
    • Bukowski, Ronald M.
    Publication type:
    Article
    11
    12
    13

    Overcoming autopsy barriers in pediatric cancer research.

    Published in:
    Pediatric Blood & Cancer, 2013, v. 60, n. 2, p. 204, doi. 10.1002/pbc.24320
    By:
    • Alabran, Jennifer L.;
    • Hooper, Jody E.;
    • Hill, Melissa;
    • Smith, Sandra E.;
    • Spady, Kimberlee K.;
    • Davis, Lara E.;
    • Peterson, Lauren S.;
    • Malempati, Suman;
    • Ryan, Christopher W.;
    • Acosta, Rae;
    • Spunt, Sheri L.;
    • Keller, Charles
    Publication type:
    Article
    14
    15
    16

    Safety and Efficacy of Sorafenib in Elderly Patients Treated in the North American Advanced Renal Cell Carcinoma Sorafenib Expanded Access Program.

    Published in:
    Oncology, 2010, v. 78, n. 5/6, p. 340, doi. 10.1159/000320223
    By:
    • Bukowski, Ronald M.;
    • Stadler, Walter M.;
    • McDermott, David F.;
    • Dutcher, Janice P.;
    • Knox, Jennifer J.;
    • Miller Jr., Wilson H.;
    • Hainsworth, John D.;
    • Henderson, Charles A.;
    • Hajdenberg, Julio;
    • Kindwall-Keller, Tamila L.;
    • Ernstoff, Marc S.;
    • Drabkin, Harry A.;
    • Curti, Brendan D.;
    • Chu, Luis;
    • Ryan, Christopher W.;
    • Hotte, Sebastien J.;
    • Chenghua Xia;
    • Cupit, Lisa;
    • Figlin, Robert A.
    Publication type:
    Article
    17
    18
    19

    A molecular case report.

    Published in:
    Cancer Biology & Therapy, 2013, v. 14, n. 2, p. 95, doi. 10.4161/cbt.22960
    By:
    • Kulesz-Martin, Molly;
    • Lagowski, James;
    • Olson, Susan;
    • Wortham, Aaron;
    • West, Toni;
    • Thomas, George;
    • Ryan, Christopher W.;
    • Tyner, Jefrey W.
    Publication type:
    Article
    20
    21
    22
    23

    Diethylstilbestrol and Docetaxel.

    Published in:
    Cancer (0008543X), 2007, v. 110, n. 5, p. 996, doi. 10.1002/cncr.22917
    By:
    • Montgomery, R. Bruce;
    • Nelson, Peter S.;
    • Lin, Daniel;
    • Ryan, Christopher W.;
    • Garzotto, Mark;
    • Beer, Tomasz M.
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    A phase 4, multicenter, global clinical study to evaluate discontinuation and rechallenge of pexidartinib in patients with tenosynovial giant cell tumor previously treated with pexidartinib.

    Published in:
    Cancer (0008543X), 2025, v. 131, n. 1, p. 1, doi. 10.1002/cncr.35634
    By:
    • Desai, Jayesh;
    • Wagner, Andrew J.;
    • Carrasco Garcia, Irene;
    • Cesari, Marilena;
    • Gordon, Michael;
    • Lin, Chia‐Chi;
    • Papai, Zsuzsanna;
    • Ryan, Christopher W.;
    • Tap, William D.;
    • Trent, Jonathan C.;
    • Gelderblom, Hans;
    • Grimison, Peter;
    • López Pousa, Antonio;
    • Van Tine, Brian A.;
    • Rubinacci, Maria;
    • Dai, Dong;
    • Rajper, Abdul Waheed;
    • Tecson, Kristen;
    • Wooddell, Margaret;
    • Stacchiotti, Silvia
    Publication type:
    Article
    37

    SWOG 1609 cohort 48: anti–CTLA‐4 and anti–PD‐1 for advanced gallbladder cancer.

    Published in:
    Cancer (0008543X), 2024, v. 130, n. 17, p. 2918, doi. 10.1002/cncr.35243
    By:
    • Patel, Sandip P.;
    • Guadarrama, Elizabeth;
    • Chae, Young Kwang;
    • Dennis, Michael J.;
    • Powers, Benjamin C.;
    • Liao, Chih‐Yi;
    • Ferri, William A.;
    • George, Thomas J.;
    • Sharon, Elad;
    • Ryan, Christopher W.;
    • Othus, Megan;
    • Lopez, Gabby;
    • Blanke, Charles D.;
    • Kurzrock, Razelle
    Publication type:
    Article
    38

    A phase II basket trial of Dual Anti–CTLA–4 and Anti–PD–1 Blockade in Rare Tumors (DART) SWOG S1609: High‐grade neuroendocrine neoplasm cohort.

    Published in:
    Cancer (0008543X), 2021, v. 127, n. 17, p. 3194, doi. 10.1002/cncr.33591
    By:
    • Patel, Sandip Pravin;
    • Mayerson, Edward;
    • Chae, Young Kwang;
    • Strosberg, Jonathan;
    • Wang, Jue;
    • Konda, Bhavana;
    • Hayward, Jourdain;
    • McLeod, Christine M.;
    • Chen, Helen X.;
    • Sharon, Elad;
    • Othus, Megan;
    • Ryan, Christopher W.;
    • Plets, Melissa;
    • Blanke, Charles D.;
    • Kurzrock, Razelle
    Publication type:
    Article
    39

    Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC).

    Published in:
    2021
    By:
    • Harrison, Michael R.;
    • Costello, Brian A.;
    • Bhavsar, Nrupen A.;
    • Vaishampayan, Ulka;
    • Pal, Sumanta K.;
    • Zakharia, Yousef;
    • Jim, Heather S. L.;
    • Fishman, Mayer N.;
    • Molina, Ana M.;
    • Kyriakopoulos, Christos E.;
    • Tsao, Che‐Kai;
    • Appleman, Leonard J.;
    • Gartrell, Benjamin A.;
    • Hussain, Arif;
    • Stadler, Walter M.;
    • Agarwal, Neeraj;
    • Pachynski, Russell K.;
    • Hutson, Thomas E.;
    • Hammers, Hans J.;
    • Ryan, Christopher W.
    Publication type:
    journal article
    40

    A Phase 1/2, open label dose-escalation and expansion trial of NKT2152, an orally administered HIF2α inhibitor, to investigate safety, PK, PD and clinical activity in patients with advanced ccRCC.

    Published in:
    Oncologist, 2023, v. 28, p. S12, doi. 10.1093/oncolo/oyad216.019
    By:
    • Jonasch, Eric;
    • Hauke, Ralph;
    • Falchook, Gerald;
    • Logan, Theodore;
    • Gordon, Michael;
    • Hall, Evan;
    • Schuch, Brian;
    • Bilen, Mehmet A;
    • Naqash, Abdul;
    • Zakaharia, Yousef;
    • Ryan, Christopher W;
    • Lally, Satwant;
    • Xiao, Jim;
    • Zimmerman, Zachary;
    • Srinivasan, Ramaprasad;
    • Choueiri, Toni K
    Publication type:
    Article
    41
    42

    A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 2, p. 1532, doi. 10.1002/cam4.5044
    By:
    • Attia, Steven;
    • Bolejack, Vanessa;
    • Ganjoo, Kristen N.;
    • George, Suzanne;
    • Agulnik, Mark;
    • Rushing, Daniel;
    • Loggers, Elizabeth T.;
    • Livingston, Michael B.;
    • Wright, Jennifer;
    • Chawla, Sant P.;
    • Okuno, Scott H.;
    • Reinke, Denise K.;
    • Riedel, Richard F.;
    • Davis, Lara E.;
    • Ryan, Christopher W.;
    • Maki, Robert G.
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50